Ryan Bond
Corporate Officer/Principal presso ACLARION, INC.
Patrimonio netto: 491 $ in data 30/04/2024
Profilo
Ryan Bond is currently the Chief Strategy Officer at Aclarion, Inc. He previously worked as the Director-Healthcare Solutions at NuVasive, Inc. from 2014 to 2018.
Mr. Bond completed his undergraduate degree at The Ohio University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ACLARION, INC.
0.02% | 30/09/2023 | 1 250 ( 0.02% ) | 491 $ | 30/04/2024 |
Posizioni attive di Ryan Bond
| Società | Posizione | Inizio |
|---|---|---|
| ACLARION, INC. | Corporate Officer/Principal | 15/09/2021 |
Precedenti posizioni note di Ryan Bond
| Società | Posizione | Fine |
|---|---|---|
| NUVASIVE, INC. | Corporate Officer/Principal | 01/09/2018 |
Formazione di Ryan Bond
| The Ohio University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ACLARION, INC. | Technology Services |
| Aziende private | 1 |
|---|---|
NuVasive, Inc.
 NuVasive, Inc. Medical SpecialtiesHealth Technology NuVasive, Inc. engages in the development, manufacture, sale, and provision of procedural solutions for spine surgery. It offers a comprehensive portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. The company was founded by Alexis V. Lukianov on July 21, 1997 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Ryan Bond
